Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids

This publication has 29 references indexed in Scilit:

• Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
  New England Journal of Medicine, 2003
• Safety and Efficacy Results of a Randomized Trial Comparing Adjuvant Toremifene and Tamoxifen in Postmenopausal Patients With Node-Positive Breast Cancer
  Journal of Clinical Oncology, 2000
• Meta‐analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer
  Breast Cancer Research and Treatment, 1999
• Tamoxifen for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Comparison of Effects of Tamoxifen and Toremifene on Bone Biochemistry and Bone Mineral Density in Postmenopausal Breast Cancer Patients
  Journal of Clinical Endocrinology & Metabolism, 1998
• Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women After 5 Years of Treatment
  JNCI Journal of the National Cancer Institute, 1994
• Hypercholesterolemia in Postmenopausal Women
  Published by American Medical Association (AMA) ,1994
• A new triphenylethylene compound, Fc-1157a
  Cancer Chemotherapy and Pharmacology, 1986
• Tamoxifen in advanced breast cancer
  Cancer Treatment Reviews, 1978
• High density lipoprotein as a protective factor against coronary heart disease
  The American Journal of Medicine, 1977